Concord Biotech consolidated net profit declines 15.07% in the December 2025 quarter
(12 Feb 2026)

Back
Net profit of Concord Biotech declined 15.07% to Rs 64.48 crore in the quarter ended December 2025 as against Rs 75.92 crore during the previous quarter ended December 2024. Sales rose 13.74% to Rs 277.77 crore in the quarter ended December 2025 as against Rs 244.22 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales277.77244.22 14
OPM %35.3840.11 -
PBDT108.18114.42 -5
PBT89.44101.15 -12
NP64.4875.92 -15

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew